Neurosense Therapeutics Ltd. · NASDAQ:NRSN
Eisenberg Or received 200,000 Neurosense Therapeutics Ltd. shares as an award (Form 4)
Traded Mar 26, 2026 · Filed Apr 1, 2026
On Mar 26, 2026, Eisenberg Or (Chief Financial Officer) received 200,000 Neurosense Therapeutics Ltd. shares as an award, leaving 1,254,050 shares. Filed Apr 1, 2026 (Form 4).
- Awarded
- 200,000 shares
- Holding after
- 1,254,050 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Mar 26, 2026 | Ordinary Shares | Award | 200,000 | 1,254,050 | Direct |